FTC sues major pharmacy benefit managers around insulin selling prices The company introduced action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the record price of existence-saving insulin medication. Elevance lowers direction on ‘unparalleled’ Medicaid worries Executives said the elevated fees pr... https://labelthefigurewiththeitem86263.bloggip.com/30673184/facts-about-healthcare-news-revealed